08 Oct 2025 Confo Therapeutics awarded VLAIO grant for development of ultra-long-acting antibody-based GPCR therapeutics in endocrine and metabolic conditions Multiple categories
24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
19 Sep 2025 STEP4NAMs — Biovia joins European effort to boost animal replacement methods Multiple categories
16 Sep 2025 Aphea.Bio wins VLAIO grant to evolve from pioneer to powerhouse in biological solutions for farmers Multiple categories
23 Jul 2025 KU Leuven researchers identify promising drug for treating severe malaria Multiple categories
11 Jun 2025 Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU Multiple categories
28 Apr 2025 argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us